Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The neurobiology of non-coding RNAs and Alzheimer’s disease pathogenesis: Pathways, mechanisms and translational opportunities
Elisabetta Lauretti, Konrad Dabrowski, Domenico Praticò
Ageing Research Reviews (2021) Vol. 71, pp. 101425-101425
Open Access | Times Cited: 73

Showing 26-50 of 73 citing articles:

Mitochondrial Small RNA Alterations Associated with Increased Lysosome Activity in an Alzheimer’s Disease Mouse Model Uncovered by PANDORA-seq
Xudong Zhang, Junchao Shi, Pratish Thakore, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3019-3019
Open Access
Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression
Linwen Zeng, Shaofeng Yuan, Pengfei Zhou, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 11795-11810
Open Access | Times Cited: 27
Circ_0003611 acts as a miR-885-5p sponge to aggravate the amyloid-β-induced neuronal injury in Alzheimer’s disease
Weihua Pan, Yirui Hu, Lihong Wang, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 4, pp. 961-971
Closed Access | Times Cited: 17
MicroRNA-195 liposomes for therapy of Alzheimer's disease
Dan Su, Zhong Chen, Xiaobin An, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 583-601
Closed Access | Times Cited: 10
Current state of research on copper complexes in the treatment of breast cancer
Kui Hu, Jingna Guo, Jiemin Zeng, et al.
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Role of tRNA-Derived Fragments in Neurological Disorders: a Review
Blessy Aksa Mathew, Madhumitha Katta, Abhilash Ludhiadch, et al.
Molecular Neurobiology (2022) Vol. 60, Iss. 2, pp. 655-671
Closed Access | Times Cited: 15
MiR-431 attenuates synaptic plasticity and memory deficits in APPswe/PS1dE9 mice
Jianwei Ge, Zhiwei Xue, Shu Shu, et al.
JCI Insight (2023) Vol. 8, Iss. 12
Open Access | Times Cited: 9
Research Progress of circRNAs in Glioblastoma
Xu Guo, Haozhe Piao
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 19
PIWI-interacting RNAs in human diseases: databases and computational models
Tianjiao Zhang, Liang Chen, Rongzhen Li, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 4
Closed Access | Times Cited: 13
TARBP2-stablized SNHG7 regulates blood-brain barrier permeability by acting as a competing endogenous RNA to miR-17-5p/NFATC3 in Aβ-microenvironment
Hao Ning, Lu Zhang, Baicheng Zhu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 12
Downregulation of Neurofilament Light Chain Expression in Human Neuronal-Glial Cell Co-Cultures by a Microbiome-Derived Lipopolysaccharide-Induced miRNA-30b-5p
Aileen I. Pogue, Vivian Jaber, Nathan M. Sharfman, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 12
Consistency of mouse models with human intracerebral hemorrhage: core targets and non-coding RNA regulatory axis
Sinan Jin, Jincheng Meng, Chong Zhang, et al.
Aging (2024)
Open Access | Times Cited: 2
The Association between Long Non-Coding RNAs and Alzheimer’s Disease
Carson M. Black, Anneliesse A. Braden, Samia Nasim, et al.
Brain Sciences (2024) Vol. 14, Iss. 8, pp. 818-818
Open Access | Times Cited: 2
A novel sand cat swarm optimization algorithm-based SVM for diagnosis imaging genomics in Alzheimer’s disease
Luyun Wang, Jinhua Sheng, Qiao Zhang, et al.
Cerebral Cortex (2024) Vol. 34, Iss. 8
Closed Access | Times Cited: 2
Biofluid biomarkers for Alzheimer’s disease: past, present, and future
Chunju An, Hui Cai, Ziye Ren, et al.
Medical Review (2024) Vol. 4, Iss. 6, pp. 467-491
Open Access | Times Cited: 2
The Role of Non-Coding RNAs in Mitochondrial Dysfunction of Alzheimer’s Disease
Samin Abed, Amir Ebrahimi, Fatemeh Fattahi, et al.
Journal of Molecular Neuroscience (2024) Vol. 74, Iss. 4
Closed Access | Times Cited: 2
The Relationship between the Aberrant Long Non-Coding RNA-Mediated Competitive Endogenous RNA Network and Alzheimer’s Disease Pathogenesis
Zhongdi Cai, Kaiyue Zhao, Li Zeng, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8497-8497
Open Access | Times Cited: 10
New Insights into lncRNAs in Aβ Cascade Hypothesis of Alzheimer’s Disease
Yitong Hao, Bo Xie, Xiaoshu Fu, et al.
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1802-1802
Open Access | Times Cited: 9
Exploring the Genetic Predisposition to Epigenetic Changes in Alzheimer’s Disease
L. O. Bryzgalov, Elena E. Korbolina, Т. И. Меркулова
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7955-7955
Open Access | Times Cited: 5
Multi-layered transcriptomic analysis reveals a pivotal role of FMR1 and other developmental genes in Alzheimer's disease-associated brain ceRNA network
Rafael Mina Piergiorge, Ronaldo da Silva Francisco, Ana Tereza Ribeiro de Vasconcelos, et al.
Computers in Biology and Medicine (2023) Vol. 166, pp. 107494-107494
Closed Access | Times Cited: 5
Establishing a competing endogenous RNA (ceRNA)-immunoregulatory network associated with the progression of Alzheimer’s disease
Yinghao Li, Hongshuo Shi, Tingting Chen, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 2, pp. 65-65
Open Access | Times Cited: 8
Associations between non-coding RNAs genetic polymorphisms with ovarian cancer risk: A systematic review and meta-analysis update with trial sequential analysis
Huaying Liu, Lili Sun, Xiaoping Liu, et al.
Medicine (2023) Vol. 102, Iss. 39, pp. e35257-e35257
Open Access | Times Cited: 4
Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s Disease
Nidhi Puranik, Minseok Song
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9936-9936
Open Access | Times Cited: 1
ceRNA Network Analysis Reveals AP-1 Transcription Factor Components as Potential Biomarkers for Alzheimer’s Disease
Rui Wei, Qi Hu, Yanjun Lu, et al.
Current Alzheimer Research (2022) Vol. 19, Iss. 5, pp. 387-406
Closed Access | Times Cited: 7
Current advances in our understanding of circular RNA (circRNA) in Alzheimer’s disease (AD); the potential utilization of synthetic circRNAs as a therapeutic strategy in the clinical management of AD
Yuhai Zhao, Vivian Jaber, Walter J. Lukiw
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 7

Scroll to top